Shares of Achaogen Inc. (NASDAQ:AKAO) were down 6.4% on Monday . The stock traded as low as $3.68 and last traded at $3.68, with a volume of 61,924 shares trading hands. The stock had previously closed at $3.93.

Several analysts recently weighed in on AKAO shares. Zacks Investment Research raised shares of Achaogen from a “hold” rating to a “buy” rating and set a $4.50 target price on the stock in a report on Wednesday, July 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of Achaogen in a report on Monday, May 9th. Finally, Wedbush reaffirmed a “neutral” rating and issued a $7.00 target price on shares of Achaogen in a report on Friday, May 6th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock presently has a consensus rating of “Buy” and an average price target of $10.63.

The company’s market capitalization is $67.19 million. The stock’s 50-day moving average is $3.96 and its 200 day moving average is $3.62.

Achaogen, Inc is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of antibacterials to treat multi-drug resistant (MDR) gram-negative infections. The Company is developing plazomicin, its lead product candidate, for the treatment of serious bacterial infections due to MDR Enterobacteriaceae, including carbapenem-resistant enterobacteriaceae (CRE).

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.